Therapeutic peptides: historical perspectives, current development trends, and future directions
The department has not yet announced conclusions or next steps from the aspiration pneumonia review in the Mounjaro SBD record, which was last updated October 24, 2025 [Source: dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00629]
From celebrities looking to drop a few pounds for the red carpet to people managing diabetes or obesity, GLP-1 drugs have become a popular weight management tool
As a GLP-1 receptor agonist, semaglutide is typically well-tolerated and offers a reliable option to help patients reduce appetite, lower calorie intake, and achieve gradual, sustainable weight loss
This peptide has shown promise in treating a range of conditions, from wound healing to neurological recovery, positioning it as a promising compound in pharmacology